Skip to content
  • Sunday, 26 July 2026
  • 12:45 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • 12 Practical Strategies to Drastically Reduce LLM Latency and Inference Costs in Production
Data Science & Bioinformatics

12 Practical Strategies to Drastically Reduce LLM Latency and Inference Costs in Production

Evan Lee Salim Jul 14, 2026 0

The rapid proliferation of Large Language Models (LLMs) in enterprise applications has unveiled a critical challenge: the escalating costs and…

Read More
Pharmaceutical R&D

Merative MarketScan Podcast Launches Season Two Exploring Real-World Healthcare Costs

Teuku Ryan May 26, 2026 0

The second season of the Merative MarketScan podcast has commenced, with its inaugural episode delving into the intricate and often…

Read More
Laboratory Automation & Robotics

From list price to net price: How finance leaders decode real drug costs

Lana Keisha May 5, 2026 0

In the complex tapestry of the healthcare industry, discussions surrounding drug pricing frequently commence and conclude with the list price.…

Read More
Laboratory Automation & Robotics

From list price to net price: How finance leaders decode real drug costs

Lana Keisha Apr 27, 2026 0

In the intricate landscape of the healthcare industry, public discourse surrounding drug pricing frequently fixates on the list price. Annual…

Read More
Laboratory Automation & Robotics

From list price to net price: How finance leaders decode real drug costs

Lana Keisha Apr 19, 2026 0

In the intricate landscape of the healthcare industry, discussions surrounding drug pricing often commence and conclude with the enigmatic "list…

Read More
Laboratory Automation & Robotics

From List Price to Net Price: How Finance Leaders Decode Real Drug Costs

Lana Keisha Apr 12, 2026 0

In the intricate landscape of the healthcare industry, public discourse surrounding drug pricing frequently begins and ends with the list…

Read More
Laboratory Automation & Robotics

From list price to net price: How finance leaders decode real drug costs

Lana Keisha Apr 5, 2026 0

In the complex landscape of the healthcare industry, public discourse surrounding drug pricing frequently begins and ends with the list…

Read More
Laboratory Automation & Robotics

From List Price to Net Price: How Finance Leaders Decode Real Drug Costs

Lana Keisha Mar 28, 2026 0

In the intricate landscape of the healthcare industry, the discourse surrounding drug pricing frequently fixates on the list price. Public…

Read More
Laboratory Automation & Robotics

From List Price to Net Price: How Finance Leaders Decode Real Drug Costs

Lana Keisha Mar 21, 2026 0

In the intricate landscape of the healthcare industry, public discourse and policy debates surrounding drug pricing frequently anchor on the…

Read More
Laboratory Automation & Robotics

From list price to net price: How finance leaders decode real drug costs

Lana Keisha Mar 14, 2026 0

In the intricate landscape of the healthcare industry, discussions surrounding drug pricing frequently commence and conclude with the list price.…

Read More
GSK Secures US Approval for Jideytro in ROS1-Positive Lung Cancer, Entering Competitive MarketA decade in the making: How functional NAMs are redefining cardiac safety assessmentYale Research Unveils Molecular Mechanism Behind Sperm-Egg Fusion Interference and Its Potential for Reproductive MedicineLab Skills on the Rise, Says LinkedIn’s Latest Report
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ